Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

被引:49
作者
Zanchetti, Alberto [1 ,2 ]
Mancia, Giuseppe [3 ]
Black, Henry R. [4 ]
Oparil, Suzanne [5 ]
Waeber, Bernard [6 ]
Schmieder, Roland E. [7 ]
Bakris, George L. [8 ]
Messerli, Franz H. [9 ]
Kjeldsen, Sverre E. [10 ]
Ruilope, Luis M. [11 ]
机构
[1] Univ Milan, Ctr Fisiol Clin & Ipertens, I-20122 Milan, Italy
[2] Ist Auxol Italiano, Milan, Italy
[3] Univ Milano Bicocca, Osped San Gerardo, Med Clin, Monza, Italy
[4] NYU, Sch Med, New York, NY USA
[5] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[6] CHU Vaudois, Dept Med, Div Hypertens, CH-1011 Lausanne, Switzerland
[7] Univ Hosp, Dept Hypertens & Nephrol, Erlangen, Germany
[8] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[9] St Lukes Roosevelt Hosp, New York, NY USA
[10] Ullevaal Univ Hosp, Dept Internal Med, Oslo, Norway
[11] Hosp 12 Octubre, Hypertens Unit, E-28041 Madrid, Spain
关键词
antihypertensive agents; blood pressure determination; cardiovascular diseases; hypertension; CONVERTING-ENZYME-INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; RENAL-DISEASE; RECEPTOR BLOCKER; DUAL BLOCKADE; DOUBLE-BLIND; STROKE; PREVENTION; REDUCTION;
D O I
10.1097/HJH.0b013e3283298ea2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A large body of clinical trial data indicates that a given difference in blood pressure (BP), as measured in the clinic, results in a given difference in outcome. This correlation underpins current US and European guidelines for the management of hypertension. However, findings from recent comparative trials may appear inconsistent with a fixed relationship between BP lowering and outcome benefit, at least at all BP ranges, at all levels of total cardiovascular risk and with all drug combinations. We review the findings of six of these recent trials and conclude that their complex design precludes a simple interpretation, that several important questions remain unanswered and that direct evidence particularly in support of lowering systolic BP below 140 or 130 mmHg - is urgently needed. J Hypertens 27:673-679 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:673 / 679
页数:7
相关论文
共 39 条
[21]  
MESSERLI FH, 2008, NEW ENGL J MED, V972, P359
[22]  
Messerli FH, 2008, NEW ENGL J MED, V359, P972
[23]   Dogma disputed: Can aggressively hypertensive patients with coronary artery lowering blood pressure in disease be dangerous? [J].
Messerli, Franz H. ;
Mancia, Giuseppe ;
Conti, C. Richard ;
Hewkin, Ann C. ;
Kupfer, Stuart ;
Champion, Annette ;
Kolloch, Rainer ;
Benetos, Athanase ;
Pepine, Carl J. .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :884-893
[24]   Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and Lisinopril microalbuminuria (CALM) study [J].
Mogensen, CE ;
Neldam, S ;
Tikkanen, I ;
Oren, S ;
Viskoper, R ;
Watts, RW ;
Cooper, ME .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7274) :1440-1444
[25]   RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial (Retracted article. See vol. 374, pg. 1226, 2009) [J].
Nakao, N ;
Yoshimura, A ;
Morita, H ;
Takada, M ;
Kayano, T ;
Ideura, T .
LANCET, 2003, 361 (9352) :117-124
[26]   European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring [J].
Parati, Gianfranco ;
Stergiou, George S. ;
Asmar, Roland ;
Bilo, Grzegorz ;
de Leeuw, Peter ;
Imai, Yutaka ;
Kario, Kazuomi ;
Lurbe, Empar ;
Manolis, Athanasios ;
Mengden, Thomas ;
O'Brien, Eoin ;
Ohkubo, Takayoshi ;
Padfield, Paul ;
Palatini, Paolo ;
Pickering, Thomas ;
Redon, Josep ;
Revera, Miriam ;
Ruilope, Luis M. ;
Shennan, Andrew ;
Staessen, Jan A. ;
Tisler, Andras ;
Waeber, Bernard ;
Zanchetti, Alberto ;
Mancia, Giuseppe .
JOURNAL OF HYPERTENSION, 2008, 26 (08) :1505-1530
[27]   Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial [J].
Patel, A. ;
MacMahon, S. ;
Chalmers, J. ;
Neal, B. ;
Woodward, M. ;
Billot, L. ;
Harrap, S. ;
Poulter, N. ;
Marre, M. ;
Cooper, M. ;
Glasziou, P. ;
Grobbee, D. E. ;
Hamet, P. ;
Heller, S. ;
Liu, L. S. ;
Mancia, G. ;
Mogensen, C. E. ;
Pan, C. Y. ;
Rodgers, A. ;
Williams, B. .
LANCET, 2007, 370 (9590) :829-840
[28]   Renin-angiotensin blockade and kidney disease [J].
Sarafidis, Pantelis A. ;
Bakris, George L. .
LANCET, 2008, 372 (9638) :511-512
[29]   Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES) [J].
Schrader, J ;
Lüders, S ;
Kulschewski, A ;
Hammersen, F ;
Plate, K ;
Berger, J ;
Zidek, W ;
Dominiak, P ;
Diener, HC .
STROKE, 2005, 36 (06) :1218-1224
[30]  
SLEIGHT P, 2008, ANN M EUR SOC CARD M